Two newer approaches to management of major hemorrhage missed the mark in randomized clinical trials published in a special transfusion-related issue of JAMA. In the CRYOSTAT-2 trial, adding early, ...

For patients with nontraumatic, out-of-hospital cardiac arrest (OHCA), evolving technology in the form of resuscitative endovascular balloon occlusion of the aorta, as well as expanded use of ...

San Antonio, TX ., Pryor Medical Devices (The REBOA Company TM), today announced it has received FDA 510(k) clearance for the sale and distribution of its ER-REBOA TM catheter. REBOA (Resuscitative ...

U.S. Department of Defense awards Prytime Medical grant to study the clinical outcomes of the world's first and only catheter designed for Partial REBOA, pREBOA-PRO™ "Partial REBOA delivered with ...

Dr. Chance Spalding uses the REBOA technique to help victims of car crashes or shootings at Grant Medical Center. A small balloon could be one of the best bets for Columbus doctors to save gunshot ...

LONDON, Ontario, June 29, 2021 (GLOBE NEWSWIRE) -- Front Line Medical Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its COBRA-OS™ (Control of Bleeding ...

REBOA is a minimally invasive technique used by the trauma, critical care and emergency medicine community to temporarily occlude large vessels using a balloon. Pryor Medical Devices has received U.S.

MADIGAN ARMY MEDICAL CENTER, Joint Base Lewis-McChord, Wash. -- Surgical research at Madigan Army Medical Center directly contributed to new trauma medical procedures to address the top cause of ...